SLC3A2 and brain cancer: CD98 is also overexpressed in tumor and inflammatory cells [114] and has been targeted by various NP formulations to amplify their internalization in diseased tissues [112], though studies targeting CD98 for neurodegenerative disease and brain cancer therapy has been limited.